Literature DB >> 26360952

[Polypharmacy in the elderly - choosing wisely by using the FORTA list].

Martin Wehling1, Christina Throm1.   

Abstract

Multimorbidity and polypharmacy are threats to elderly patients; improvement of medication is important and a novel listing approach - the FORTA [Fit fOR The Aged] list - should support this in clinical practice. Here, we aim to describe procedural details of successful application of FORTA. FORTA labels range from A (indispensable), B (beneficial), C (questionable) to D (avoid), depending on evidence for safety, efficacy and overall age-appropriateness. As an implicit tool, it is only applicable if medical details of the patient are known. The process starts with history taking and diagnostic assessment including disease grading. This is the base for FORTA-assisted selection of drugs to avoid overtreatment (drug not necessary), undertreatment (condition not or not sufficiently treated by positively labeled drugs) or mistreatment (drugs indicated, but negatively rather than positively labeled drug chosen). Selection is followed by secondary analyses, e. g. regarding dosing or contraindications. The medication scheme is updated in reflection of wanted clinical effects (e. g. blood pressure lowering) and side effects (e. g. dizziness). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26360952     DOI: 10.1055/s-0041-103205

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  [Cardiovascular pharmacotherapy in the elderly : To avoid overtreatment and undertherapy].

Authors:  J Bauersachs; M Wehling
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

Review 2.  [Drug therapy for older people : Choosing wisely].

Authors:  Martin Wehling
Journal:  Z Gerontol Geriatr       Date:  2017-09-22       Impact factor: 1.281

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.